These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30219827)

  • 61. Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication.
    Esser-Nobis K; Harak C; Schult P; Kusov Y; Lohmann V
    Hepatology; 2015 Aug; 62(2):397-408. PubMed ID: 25866017
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors.
    Einav S; Sobol HD; Gehrig E; Glenn JS
    J Infect Dis; 2010 Jul; 202(1):65-74. PubMed ID: 20486856
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Foot-and-mouth disease virus genome replication is unaffected by inhibition of type III phosphatidylinositol-4-kinases.
    Loundras EA; Herod MR; Harris M; Stonehouse NJ
    J Gen Virol; 2016 Sep; 97(9):2221-2230. PubMed ID: 27323707
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phosphoinositides in the hepatitis C virus life cycle.
    Bishé B; Syed G; Siddiqui A
    Viruses; 2012 Oct; 4(10):2340-58. PubMed ID: 23202467
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.
    De Palma AM; Thibaut HJ; van der Linden L; Lanke K; Heggermont W; Ireland S; Andrews R; Arimilli M; Al-Tel TH; De Clercq E; van Kuppeveld F; Neyts J
    Antimicrob Agents Chemother; 2009 May; 53(5):1850-7. PubMed ID: 19237651
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A small molecule inhibits HCV replication and alters NS4B's subcellular distribution.
    Bryson PD; Cho NJ; Einav S; Lee C; Tai V; Bechtel J; Sivaraja M; Roberts C; Schmitz U; Glenn JS
    Antiviral Res; 2010 Jul; 87(1):1-8. PubMed ID: 20363257
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication.
    Obeid S; Alen J; Nguyen VH; Pham VC; Meuleman P; Pannecouque C; Le TN; Neyts J; Dehaen W; Paeshuyse J
    PLoS One; 2013; 8(12):e81783. PubMed ID: 24349127
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Exploration for anti-enterovirus compounds and analysis on the mechanism of its inhibitory effect on virus infection].
    Arita M
    Uirusu; 2013; 63(1):93-102. PubMed ID: 24769585
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus.
    Heinz BA; Vance LM
    J Virol; 1995 Jul; 69(7):4189-97. PubMed ID: 7769678
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells.
    Raj M; Langley M; McArthur SJ; Jean F
    J Gen Virol; 2017 May; 98(5):977-991. PubMed ID: 28548037
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Casein kinase II inhibitor enhances production of infectious genotype 1a hepatitis C virus (H77S).
    Kim S; Jin B; Choi SH; Han KH; Ahn SH
    PLoS One; 2014; 9(12):e113938. PubMed ID: 25464014
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro.
    Migliaccio G; Tomassini JE; Carroll SS; Tomei L; Altamura S; Bhat B; Bartholomew L; Bosserman MR; Ceccacci A; Colwell LF; Cortese R; De Francesco R; Eldrup AB; Getty KL; Hou XS; LaFemina RL; Ludmerer SW; MacCoss M; McMasters DR; Stahlhut MW; Olsen DB; Hazuda DJ; Flores OA
    J Biol Chem; 2003 Dec; 278(49):49164-70. PubMed ID: 12966103
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses.
    Grazia Martina M; Vicenti I; Bauer L; Crespan E; Rango E; Boccuto A; Olivieri N; Incerti M; Zwaagstra M; Allodi M; Bertoni S; Dreassi E; Zazzi M; van Kuppeveld FJM; Maga G; Radi M
    ChemMedChem; 2021 Dec; 16(23):3548-3552. PubMed ID: 34382337
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Understanding the selectivity of inhibitors toward PI4KIIIα and PI4KIIIβ based molecular modeling.
    Tian S; Zeng J; Liu X; Chen J; Zhang JZH; Zhu T
    Phys Chem Chem Phys; 2019 Oct; 21(39):22103-22112. PubMed ID: 31570909
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes.
    Bartolomei G; Cevik RE; Marcello A
    J Gen Virol; 2011 Sep; 92(Pt 9):2072-2081. PubMed ID: 21593278
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase.
    Mankouri J; Tedbury PR; Gretton S; Hughes ME; Griffin SD; Dallas ML; Green KA; Hardie DG; Peers C; Harris M
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11549-54. PubMed ID: 20534540
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA.
    Takeshita M; Ishida Y; Akamatsu E; Ohmori Y; Sudoh M; Uto H; Tsubouchi H; Kataoka H
    J Biol Chem; 2009 Aug; 284(32):21165-76. PubMed ID: 19531480
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I.
    Feigelstock DA; Mihalik KB; Kaplan G; Feinstone SM
    Virol J; 2010 Feb; 7():44. PubMed ID: 20170495
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis.
    Einav S; Gerber D; Bryson PD; Sklan EH; Elazar M; Maerkl SJ; Glenn JS; Quake SR
    Nat Biotechnol; 2008 Sep; 26(9):1019-27. PubMed ID: 18758449
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes.
    Wyde PR; Six HR; Wilson SZ; Gilbert BE; Knight V
    Antimicrob Agents Chemother; 1988 Jun; 32(6):890-5. PubMed ID: 2843086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.